EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model

Journal of Molecular Medicine

Volumn 85, Issue 9, 2007, Pages 1015-1029

  González, Iranzu ^b   Vicent, Silvestre ^b   De Alava, Enrique ^a   Lecanda, Fernando ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Ewing sarcoma; Gene repression; Osteolysis; Sarcomagenesis; Tissue tropism; Transdifferentiation

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BONE LESION; BONE METASTASIS; BONE MINERAL; CELL LINE; CELL SIZE; CHIMERA; CONTROLLED STUDY; EWING SARCOMA; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MEDICAL ASSESSMENT; MESENCHYME; MULTIPOTENT STEM CELL; NEURITE; NEUROECTODERM TUMOR; OSTEOBLAST; PHENOTYPE; PROTEIN STRUCTURE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, INBRED C3H; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM METASTASIS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEIN C-FLI-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, EWING'S; SARCOMA, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 34548052223     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0202-5     Document Type: Article

References (53)

1. Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the US. Cancer 78(3):532-541
2. Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341(5):342-352
3. Burchill SA (2003) Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol 56(2):96-102
4. Paulussen M, Ahrens S, Craft AW, Dunst J, Frohlich B, Jabar S et al (1998) Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 16(9):3044-3052
5. Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H et al (2000) Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18(17):3108-3114
6. Mackall CL, Meltzer PS, Helman LJ (2002) Focus on sarcomas. Cancer Cell 2(3):175-178
7. de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG et al (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16(4):1248-1255
8. Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I et al (1996) Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14(4):1245-1251
9. Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH et al (2005) Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 23(3):548-558
10. Franchi A, Pasquinelli G, Cenacchi G, Della Rocca C, Gambini C, Bisceglia M et al (2001) Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma/PNET of bone and soft tissues. Ultrastruct Pathol 25(3):219-225
11. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20(40):5747-5754
12. Knoop LL, Baker SJ (2001) EWS/FLI alters 5′-splice site selection. J Biol Chem 276(25):22317-22322
13. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ (2005) EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 65(11):4633-4644
14. Gershon TR, Oppenheimer O, Chin SS, Gerald WL (2005) Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia 7(6):575-584
15. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518-524
16. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3(6):537-549
17. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453-458
18. Reznikoff CA, Brankow DW, Heidelberger C (1973) Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33(12):3231-3238
19. Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33(12):3239-3249
20. Taylor SM, Jones PA (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17(4):771-779
21. Shin CS, Lecanda F, Sheikh S, Weitzmann L, Cheng SL, Civitelli R (2000) Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways. J Cell Biochem 78(4):566-577
22. Watsuji T, Okamoto Y, Emi N, Katsuoka Y, Hagiwara M (1997) Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Biochem Biophys Res Commun 234(3):769-773
23. Lecanda F, Towler DA, Ziambaras K, Cheng SL, Koval M, Steinberg TH et al (1998) Gap junctional communication modulates gene expression in osteoblastic cells. Mol Biol Cell 9(8):2249-2258
24. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R (2000) Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151(4):931-944
25. Jiang Y, Prosper F, Verfaillie CM (2000) Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors. Blood 95(3):846-854
26. Bixel G, Kloep S, Butz S, Petri B, Engelhardt B, Vestweber D (2004) Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood 104(10):3205-3213
27. Kovar H (2005) Context matters: the hen or egg problem in Ewing's sarcoma. Semin Cancer Biol 15(3):189-196
28. Votta TJ, Fantuzzo JJ, Boyd BC (2005) Peripheral primitive neuroectodermal tumor associated with the anterior mandible: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100(5):592-597
29. Eliazer S, Spencer J, Ye D, Olson E, Ilaria RL Jr (2003) Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol Cell Biol 23(2):482-492
30. Torchia EC, Jaishankar S, Baker SJ (2003) Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res 63(13):3464-3468
31. Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR et al (2006) Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9(5):405-416
32. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr (2005) Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors. Cancer Res 65(19):8698-8705
33. Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, Garcia-Echeverria C et al (2005) Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65(24):11459-11468
34. Golub TR (2003) Mining the genome for combination therapies. Nat Med 9(5):510-511
35. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B et al (1997) Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15(18):2225-2232
36. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y (2000) Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet 120(2):91-98
37. Lopez-Guerrero JA, Pellin A, Noguera R, Carda C, Llombart-Bosch A (2001) Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 81(6):803-814
38. Szuhai K, Ijszenga M, Tanke HJ, Rosenberg C, Hogendoorn PC (2006) Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet 166(2):173-179
39. Rangarajan A, Hong SJ, Gifford A, Weinberg RA (2004) Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6(2):171-183
40. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S et al (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25(2):371-379
41. Todaro GJ, Green H (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17:299-313
42. Aaronson SA, Todaro GJ (1968) Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science 162(857):1024-1026
43. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737
44. Jamieson CH, Weissman IL, Passegue E (2004) Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell 6(6):531-533
45. Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH, Ladanyi M (1999) Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 59(7):1428-1432
46. de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindan FJ, Barr FG et al (2000) Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 156(3):849-855
47. Bernards R, Weinberg RA, van't Veer LJ, Dai H, van de Vijver MJ, He YD et al (2002) A progression puzzle. Nature 418(6900):823
48. Aryee DN, Sommergruber W, Muehlbacher K, Dockhorn-Dworniczak B, Zoubek A, Kovar H (2000) Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type. Lab Invest 80(12):1833-1844
49. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1(1):46-54
50. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563-572
51. Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70(9-10):498-505
52. Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S et al (2004) The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100(5):1053-1058
53. Schleiermacher G, Peter M, Oberlin O, Philip T, Rubie H, Mechinaud F et al (2003) Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 21(1):85-91